HK Stock MarketDetailed Quotes
02228 QUANTUMPH-P
- 5.280
- -0.020-0.38%
Market Closed Jun 28 16:08 CST
17.99BMarket Cap-8516P/E (TTM)
5.350High5.050Low8.48MVolume5.300Open5.300Pre Close44.11MTurnover0.25%Turnover RatioLossP/E (Static)3.41BShares6.58052wk High-2.24P/B17.99BFloat Cap5.05052wk Low--Dividend TTM3.41BShs Float6.580Historical High--Dividend LFY5.66%Amplitude5.050Historical Low5.202Avg Price1000Lot Size--Div YieldTTM--Div Yield LFY
About QUANTUMPH-P Company
Jingtai Technology is an innovative R&D platform company driven by artificial intelligence (AI) and robots. It was founded in 2015 by three MIT postdoctoral physicists to achieve digital and intelligent innovation in life science and new materials. The company provides innovative R&D technology, services and products for the global biomedical, chemical, new energy, new materials and other industries based on cutting-edge technologies and capabilities such as quantum physics, artificial intelligence, cloud computing, and large-scale experimental robot clusters.
Company Profile
Symbol02228
Company NameQUANTUMPH-P
ISINKYG7S12M1051
Listing DateJun 13, 2024
Issue Price5.28
Shares Offered187.37M share(s)
FoundedApr 28, 2017
Registered AddressCayman Islands
Chairmanshuhao wen
Secretarywenkangchenxiuling tan
Audit InstitutionPricewaterhouseCoopers
Company CategoryOther
Registered OfficePO Box 309 Ugland House Grand Cayman KY1-1104 Cayman Islands
Head Office and Principal Place of Business5/F, Manulife Plaza, 348 Kwun Tong Road, Kowloon, Hong Kong
Fiscal Year Ends12-31
Employees783
MarketHong Kong motherboard
Phone(021)68780786
Emailbd@xtalpi.com
Websitehttps://www.xtalpi.com
Business QuantumPharm Inc is a Chinese company that mainly provides drug discovery solutions and intelligent automation solutions. The company mainly operates through two business segments. The Drug Discovery Solution Division covers the entire drug discovery and research process, providing modular independent solutions or collaborating with various biotechnology and pharmaceutical companies and academic institutions for novel drug discovery work. The Intelligent Automation Solution Division includes solid state R&D services and automated chemical synthesis services. Solid-state R&D services include computational services, wet laboratory testing services and integrated solutions.
Company Executives
- Name
- Position
- Salary
- shuhao wen
- Chairman of the Board，Executive Director，Chairman of the Nomination Committee，Authorized Representative
- --
- jian ma
- CEOs，Executive Director，Remuneration Committee Members
- --
- lipeng lai
- Executive Director，Chief Innovation Officer
- --
- yide jiang
- Executive Director，Chief Strategy Officer
- --
- cuiping gu
- Non-executive directors
- --
- zhuojian luo
- Independent Non-Executive Director，Chairman of the Audit Committee，Remuneration Committee Chairman，Nomination Committee Members
- --
- yingqi chen
- Independent Non-Executive Director，Nomination Committee Members，Audit Committee Members
- --
- mingsheng zhou
- Independent Non-Executive Director，Remuneration Committee Members，Audit Committee Members
- --
- peiyu zhang
- Chief Scientist
- --
- wenkang tan
- chief financial officer，Joint Company Secretary，Authorized Representative
- --
- xiuling chen
- Joint Company Secretary
- --
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
%Chg